Marta Morawska
Lublin, LU, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.
Journal: Leukemia & lymphoma
Published: August 10, 2026
Corrigendum to "Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study" EClinicalMedicine. 2025 Jul 25:86:103383.
Journal: EClinicalMedicine
Published: April 21, 2026
Predicted microbiome-associated metabolic pathways are linked to immune checkpoint modulation in chronic lymphocytic leukaemia.
Journal: British journal of haematology
Published: February 25, 2026
Correction for: Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group.
Journal: Contemporary oncology (Poznan, Poland)
Published: October 16, 2025
Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma.
Journal: British journal of haematology
Published: October 09, 2025
Implementation of the Finnish Good Practice "Smart Family" in Poland.
Journal: Children (Basel, Switzerland)
Published: September 30, 2025
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 01, 2025
Retrospective analysis of primary pulmonary lymphoma cases from Polish Lymphoma Research Group centers reveals associations between initial symptoms and outcomes.
Journal: Scientific reports
Published: March 31, 2025
Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study.
Journal: EClinicalMedicine
Published: March 14, 2025
Last Updated: 09/26/2026